NDAQ:CRBU) Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025 ...

Spatial transcriptomics was named the method of the year in 2020 (Nature 2021). Spatial transcriptomics has rapidly emerged ...

Geode Capital Management LLC acquired a new position in shares of MBX Biosciences, Inc. (NYSE:MBX – Free Report) in the 3rd quarter, HoldingsChannel reports. The fund acquired 22,269 shares of the ...

Precision BioSciences gains momentum as iECURE reports positive ECUR-506 data, and analysts forecast significant HBV ...

Fintel reports that on January 10, 2025, BMO Capital upgraded their outlook for Precision BioSciences (NasdaqCM:DTIL) from ...

Is it just market speculation, or is there something more significant unfolding behind the scenes? At the core of Precision BioSciences’ sudden stock surge is the company’s gene-editing technology, ...

Precision BioSciences (DTIL) stock saw a 31% premarket surge after positive results from its gene therapy trial for treating ...

JonesTrading analyst Soumit Roy maintained a Buy rating on Precision BioSciences (DTIL – Research Report) today and set a price target of ...

Character Biosciences Announces Collaboration with Bausch + Lomb to Transform Ophthalmology with Precision Medicine ...

BMO Capital analyst Kostas Biliouris upgraded the rating on Precision BioSciences (DTIL – Research Report) to a Buy today, setting a price ...

Actio Biosciences Expands Leadership Team with Appointment of Cayce Denton as Chief Financial Officer ...